![Vladimir Zaharchook](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Vladimir Zaharchook
Director/Board Member at MEDISTEM INC
Profile
Vladimir Zaharchook is currently the Vice Chairman at Medistem, Inc. and Director at Nobilis Therapeutics, Inc. He has an undergraduate and graduate degree from Saint Petersburg State University of Economics.
Vladimir Zaharchook active positions
Companies | Position | Start |
---|---|---|
MEDISTEM INC | Director/Board Member | - |
Nobilis Therapeutics, Inc.
![]() Nobilis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nobilis Therapeutics, Inc. develops inhalation-based therapeutics for the treatment of neurologic, psychiatric, and development disorders. It develops gas mixtures that offer reproducible, standardized, and controlled patient exposure to address unmet medical needs in psychiatric and neurological disorders, including PTSD, autism, and ADHD. The company was founded by Vlad Bogin and is headquartered in Portland, OR. | Director/Board Member | - |
Training of Vladimir Zaharchook
Saint Petersburg State University of Economics | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Medistem, Inc.
![]() Medistem, Inc. Medical SpecialtiesHealth Technology Medistem, Inc. is focused on developing therapies for treating serious diseases and conditions using the natural regenerative properties of stem cells. Endometrial Regenerative Cell possess specialized abilities to stimulate new blood vessel growth and can differentiate into lung, liver, heart, brain, bone, cartilage, fat and pancreatic tissue. The company was founded by Neil H. Riordan in October 2005, and is headquartered in San Diego, CA. | Health Technology |
Nobilis Therapeutics, Inc.
![]() Nobilis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nobilis Therapeutics, Inc. develops inhalation-based therapeutics for the treatment of neurologic, psychiatric, and development disorders. It develops gas mixtures that offer reproducible, standardized, and controlled patient exposure to address unmet medical needs in psychiatric and neurological disorders, including PTSD, autism, and ADHD. The company was founded by Vlad Bogin and is headquartered in Portland, OR. | Commercial Services |
- Stock Market
- Insiders
- Vladimir Zaharchook